+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Opioid Use Disorder Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 168 Pages
  • December 2023
  • Region: Global
  • Expert Market Research
  • ID: 5926350
Global Opioid Use Disorder Market Report and Forecast 2024-2032

Market Outlook

According to the report the global opioid use disorder market is projected to grow at a CAGR of 10% between 2024 and 2032 to reach a value of about USD 7.8 billion by 2032. Aided by the escalating cases of opioid abuse and the burgeoning need for effective treatments and interventions, the market is expected to grow significantly by 2032.

Opioid use disorder (OUD) represents a chronic neurobiological condition characterised by an individual's repeated use of opioids, whether they be prescription medications or illicit substances like heroin. The consequences range from health-related issues, compromised social engagements, and a pronounced decline in the overall quality of life. The disorder’s manifestations can be multifaceted, inclusive of a strong drug craving, an inability to control or reduce consumption, and the emergence of withdrawal symptoms upon abrupt cessation.

The burgeoning incidence rate of opioid use disorder worldwide is primarily driving the opioid use disorder market growth. A heightened understanding of the debilitating nature of OUD has led to more focused efforts on prevention, early detection, and effective therapeutic interventions. In addition, the increasing prescription rate of opioid analgesics, often coupled with misuse, has ignited the pressing need for optimal treatment strategies.

Pharmaceutical advancements in opioid use disorder treatment have been influencing the global opioid use disorder market outlook. Medications such as buprenorphine, methadone, and naltrexone have gained prominence for their efficacy in not only managing withdrawal symptoms but also in reducing the likelihood of relapse. These drugs, when amalgamated with psychosocial support, have illustrated promising outcomes in the recovery trajectory of OUD patients.

Beyond pharmaceuticals, the increasing advocacy for comprehensive therapeutic approaches is augmenting the OUD market. Cognitive-behavioural therapy, contingency management, and motivational enhancement therapy are all gaining traction. These approaches, which aim at modifying the patient's thinking patterns and behaviours, hold promise in conjunction with medication-assisted treatments.

As per the opioid use disorder market analysis, the health sector's growing inclination towards technology and digital health also promises to reshape the market dynamics. Digital therapeutic solutions, inclusive of mobile apps and online support groups, are emerging as effective tools. They offer patients round-the-clock support, monitor drug usage patterns, and facilitate immediate interventions during craving episodes.

In addition, the increasing governmental and non-governmental interventions, in the form of awareness campaigns, are playing an indispensable role in highlighting the risks associated with opioid misuse and the potential pathways to recovery. These initiatives, backed by policies that stress regular physician training on opioid prescription and monitoring, are creating a robust infrastructure for combatting the OUD epidemic.

Market Segmentation

The market can be divided based on drug and region.

Market Breakup by Drug

  • Buprenorphine
  • Bunavail
  • Sublocade
  • Suboxone
  • Zubsolv
  • Others
  • Methadone
  • Naltrexone

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Competitive Landscape

The report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the leading companies operating in the global opioid use disorder market. Some of the major players explored in the report are as follows:
  • Indivior PLC
  • BioDelivery Sciences International, Inc.
  • Alkermes plc
  • Titan Pharmaceuticals, Inc.
  • Camurus AB.
  • Others

Table of Contents

1 Preface2 Report Coverage - Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Opioid Use Disorder Market Analysis
8.1 Key Industry Highlights
8.2 Global Opioid Use Disorder Historical Market (2018-2023)
8.3 Global Opioid Use Disorder Market Forecast (2024-2032)
8.4 Global Opioid Use Disorder Market by Drug
8.4.1 Buprenorphine
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.1.3 Buprenorphine by Type
8.4.1.3.1 Bunavail
8.4.1.3.2 Sublocade
8.4.1.3.3 Suboxone
8.4.1.3.4 Zubsolv
8.4.1.3.5 Others
8.4.2 Methadone
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Naltrexone
8.4.3.1 Historical Trend (2018-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.5 Global Opioid Use Disorder Market by Region
8.5.1 North America
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 Europe
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 Asia Pacific
8.5.3.1 Historical Trend (2018-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.5.4 Latin America
8.5.4.1 Historical Trend (2018-2023)
8.5.4.2 Forecast Trend (2024-2032)
8.5.5 Middle East and Africa
8.5.5.1 Historical Trend (2018-2023)
8.5.5.2 Forecast Trend (2024-2032)
9 North America Opioid Use Disorder Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Opioid Use Disorder Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Opioid Use Disorder Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Opioid Use Disorder Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Opioid Use Disorder Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis16 Price Analysis
17 Competitive Landscape
17.1 Market Structure
17.2 Company Profiles
17.2.1 Indivior PLC
17.2.1.1 Company Overview
17.2.1.2 Product Portfolio
17.2.1.3 Demographic Reach and Achievements
17.2.1.4 Certifications
17.2.2 BioDelivery Sciences International, Inc.
17.2.2.1 Company Overview
17.2.2.2 Product Portfolio
17.2.2.3 Demographic Reach and Achievements
17.2.2.4 Certifications
17.2.3 Alkermes plc
17.2.3.1 Company Overview
17.2.3.2 Product Portfolio
17.2.3.3 Demographic Reach and Achievements
17.2.3.4 Certifications
17.2.4 Titan Pharmaceuticals, Inc.
17.2.4.1 Company Overview
17.2.4.2 Product Portfolio
17.2.4.3 Demographic Reach and Achievements
17.2.4.4 Certifications
17.2.5 Camurus AB.
17.2.5.1 Company Overview
17.2.5.2 Product Portfolio
17.2.5.3 Demographic Reach and Achievements
17.2.5.4 Certifications
17.3.6 Others
18 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Opioid Use Disorder Market: Key Industry Highlights, 2018 and 2032
2. Global Opioid Use Disorder Historical Market: Breakup by Drug (USD Million), 2018-2023
3. Global Opioid Use Disorder Market Forecast: Breakup by Drug (USD Million), 2024-2032
4. Global Opioid Use Disorder Historical Market: Breakup by Region (USD Million), 2018-2023
5. Global Opioid Use Disorder Market Forecast: Breakup by Region (USD Million), 2024-2032
6. North America Opioid Use Disorder Historical Market: Breakup by Country (USD Million), 2018-2023
7. North America Opioid Use Disorder Market Forecast: Breakup by Country (USD Million), 2024-2032
8. Europe Opioid Use Disorder Historical Market: Breakup by Country (USD Million), 2018-2023
9. Europe Opioid Use Disorder Market Forecast: Breakup by Country (USD Million), 2024-2032
10. Asia Pacific Opioid Use Disorder Historical Market: Breakup by Country (USD Million), 2018-2023
11. Asia Pacific Opioid Use Disorder Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Latin America Opioid Use Disorder Historical Market: Breakup by Country (USD Million), 2018-2023
13. Latin America Opioid Use Disorder Market Forecast: Breakup by Country (USD Million), 2024-2032
14. Middle East and Africa Opioid Use Disorder Historical Market: Breakup by Country (USD Million), 2018-2023
15. Middle East and Africa Opioid Use Disorder Market Forecast: Breakup by Country (USD Million), 2024-2032
16. Global Opioid Use Disorder Market Structure

Companies Mentioned

  • Indivior PLC
  • BioDelivery Sciences International Inc.
  • Alkermes plc
  • Titan Pharmaceuticals Inc.
  • Camurus AB.

Methodology

Loading
LOADING...